University of Cambridge > Talks.cam > Synthetic Biology Strategic Research Initiative > Café Synthetique, CRISPR: genome editing comes of age

Café Synthetique, CRISPR: genome editing comes of age

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Andrew Jonathan Balmer.

Café Synthetique is the monthly meetup for the Cambridge synthetic biology community with informal talks, discussion and pub snacks.

This months’ theme will focus on genetic circuit engineering, which is the synthesis of unnatural DNA segments encoding protein or RNA molecules that control each other’s levels. Come along and learn more about this exciting technology!

We have two excellent speakers whose work focuses respectively on the use of CRISPR and the design of genetic circuits, and the application of cell engineering in Bioprocess.

Free bar snacks and good conversation provided!

Talks and speakers

Using CRISPR in Cancer research

Dr Alisdair Russell, Cambridge Cancer Centre

Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. They use these novel models in a range of pre-clinical trials to advance our understanding of disease.

Advances in genome editing: could we design the perfect cell line for the manufacture of biotherapeutics?

Dr Bruno Fievet, Senior Scientist, Applied R&D, Horizon

Bruno works as part of Products Division for applications in Bioprocess, and is using leading edge genome editing technology to develop new mammalian host cell lines for the Bioprocess Industry.

For more information, and to RSVP , click here.

This talk is part of the Synthetic Biology Strategic Research Initiative series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2021 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity